LMQ.F

Healthcare Diagnostics & Research

Oxford BioDynamics Plc

€0.00

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

6.72M

Avg Volume

856

52W High

€0.01

52W Low

€0.00

Div. Yield

0.0%

Valuation

P/B Ratio

0.43

P/S Ratio

5.62

EV/EBITDA

-0.43

EV/Revenue

3.27

Margins

Gross Margin 46.7%

Operating Margin (681.4%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

17.0%

Return on Equity

(214.9%)

Return on Assets

(53.3%)

Liquidity & Leverage

Current Ratio

2.01

Quick Ratio

1.89

Debt / Equity

1.32

Total Cash

2.51M

Total Debt

4.28M

About

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.